Logo image of LTH.CA

LITHIUM IONIC CORP (LTH.CA) Stock Fundamental Analysis

TSX-V:LTH - TSX Venture Exchange - CA53680V1076 - Common Stock - Currency: CAD

0.58  +0.05 (+9.43%)

Fundamental Rating

2

Taking everything into account, LTH scores 2 out of 10 in our fundamental rating. LTH was compared to 808 industry peers in the Metals & Mining industry. Both the profitability and financial health of LTH have multiple concerns. LTH has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year LTH has reported negative net income.
In the past year LTH has reported a negative cash flow from operations.
LTH.CA Yearly Net Income VS EBIT VS OCF VS FCFLTH.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

With a Return On Assets value of -89.35%, LTH is not doing good in the industry: 73.64% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -89.35%
ROE N/A
ROIC N/A
ROA(3y)-218.73%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LTH.CA Yearly ROA, ROE, ROICLTH.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 500 -500

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LTH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LTH.CA Yearly Profit, Operating, Gross MarginsLTH.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

3

2. Health

2.1 Basic Checks

The number of shares outstanding for LTH has been increased compared to 1 year ago.
The debt/assets ratio for LTH has been reduced compared to a year ago.
LTH.CA Yearly Shares OutstandingLTH.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M
LTH.CA Yearly Total Debt VS Total AssetsLTH.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

LTH has an Altman-Z score of -5.29. This is a bad value and indicates that LTH is not financially healthy and even has some risk of bankruptcy.
LTH has a Altman-Z score of -5.29. This is in the lower half of the industry: LTH underperforms 66.34% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.29
ROIC/WACCN/A
WACCN/A
LTH.CA Yearly LT Debt VS Equity VS FCFLTH.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M -20M -40M

2.3 Liquidity

A Current Ratio of 4.28 indicates that LTH has no problem at all paying its short term obligations.
LTH has a better Current ratio (4.28) than 72.52% of its industry peers.
A Quick Ratio of 4.28 indicates that LTH has no problem at all paying its short term obligations.
LTH's Quick ratio of 4.28 is fine compared to the rest of the industry. LTH outperforms 72.90% of its industry peers.
Industry RankSector Rank
Current Ratio 4.28
Quick Ratio 4.28
LTH.CA Yearly Current Assets VS Current LiabilitesLTH.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 50.65% over the past year.
EPS 1Y (TTM)50.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

LTH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 57.44% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y33.33%
EPS Next 2Y48.14%
EPS Next 3Y69.9%
EPS Next 5Y57.44%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LTH.CA Yearly Revenue VS EstimatesLTH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 100M 200M 300M
LTH.CA Yearly EPS VS EstimatesLTH.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 -0.4 0.6

4

4. Valuation

4.1 Price/Earnings Ratio

LTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 16.09, LTH is valued correctly.
89.36% of the companies in the same industry are more expensive than LTH, based on the Price/Forward Earnings ratio.
LTH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 16.09
LTH.CA Price Earnings VS Forward Price EarningsLTH.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LTH.CA Per share dataLTH.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LTH's earnings are expected to grow with 69.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.14%
EPS Next 3Y69.9%

0

5. Dividend

5.1 Amount

LTH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LITHIUM IONIC CORP

TSX-V:LTH (6/20/2025, 7:00:00 PM)

0.58

+0.05 (+9.43%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-29 2025-05-29
Earnings (Next)08-20 2025-08-20
Inst Owners16.94%
Inst Owner ChangeN/A
Ins Owners14.81%
Ins Owner ChangeN/A
Market Cap92.20M
Analysts84.62
Price Target4.27 (636.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)29.42%
PT rev (3m)8.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.09
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.17
EYN/A
EPS(NY)0.04
Fwd EY6.22%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -89.35%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-218.73%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1223.57%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.28
Quick Ratio 4.28
Altman-Z -5.29
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)579.67%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65%
EPS Next Y33.33%
EPS Next 2Y48.14%
EPS Next 3Y69.9%
EPS Next 5Y57.44%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y55.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.83%
EBIT Next 3Y12.31%
EBIT Next 5YN/A
FCF growth 1Y44.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y53.13%
OCF growth 3YN/A
OCF growth 5YN/A